<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="735">
  <stage>Registered</stage>
  <submitdate>15/09/2005</submitdate>
  <approvaldate>20/10/2005</approvaldate>
  <actrnumber>ACTRN12605000667617</actrnumber>
  <trial_identification>
    <studytitle>Promoting Independence in residential care</studytitle>
    <scientifictitle>Falls function and quality of life. Does a functional activity programme make a difference to functional impairment in residents in residential care: a cluster randomised controlled trial</scientifictitle>
    <utrn />
    <trialacronym>PIRC</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Functional impairment in older people in residential care</healthcondition>
    <conditioncode>
      <conditioncode1>Physical Medicine / Rehabilitation</conditioncode1>
      <conditioncode2>Other physical medicine / rehabilitation</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>* A trained research nurse conducts a functional assessment with the assistance of a physiotherapist and occupational therapist when needed
* Participant identifies a functional goal
* Research nurse designs an individualised home-based physical activity programme based on attaining the functional goal. This is written as a prescriptive activity programme
* The health care assistant and resident are taught the programme and work together to encourage resident participation
* The nurse has direct contact with the residents on 2 or 3 occasions and with the caregivers and other staff to provide support over a period of 6 months.</interventions>
    <comparator>social visits, 2 visitis over 6 weeks. the visits were conducted by a social researcher who discussed their previous and current social activtiies</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Quality of life and function: change in Late Life FDI</outcome>
      <timepoint>12 months from randomisation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of life and function: change in Timed Up and Go</outcome>
      <timepoint>12 months from randomisation</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Quality of life and function: change in Elderly mobility Scale</outcome>
      <timepoint>12 months from randomisation</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Falls, falls self efficacy</outcome>
      <timepoint>12 months from randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Balance, FICSIT 4 point balance test</outcome>
      <timepoint>12 months from randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Adverse events</outcome>
      <timepoint>2,4,6,8,12 months from randomisation</timepoint>
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Depressive symptomatology, GDS and Life Satisfaction Index (LSI-Z) over time.</outcome>
      <timepoint>12 months from randomisation</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Eligible patients include those living in low level residential care, rest homes, hostels or independent living, able to communicate in English, and not terminally ill or having a major diagnosis of anxiety. Patients with adequate cognition to undertake a conversation about setting a goal were included. This was decided during a review of all potential participants with the clinical nurse managers of residential care homes. </inclusivecriteria>
    <inclusiveminage>65</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>Not stated</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Patients will be excluded if they suffer from severe dementia, terminal illness or an unstable cardiac condition, are unable to communicate in English, or are not living in rest homes in Auckland permanently.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>An independent investigator in a distant site holds a computer-generated randomisation schedule. After completion of baseline measures of all enrolled residents in participants rest homes the recruitment nurse telephones the independent researcher. The outcome assessor will remain blind to group randomisation.</concealment>
    <sequence>computer</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Single group</assignment>
    <designfeatures>Clustered by resdiential care home</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>19/01/2004</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>685</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>New Zealand</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Government body</primarysponsortype>
    <primarysponsorname>Health Research Council of NZ</primarysponsorname>
    <primarysponsoraddress>Grafton Rd, Grafton Auckland 1001</primarysponsoraddress>
    <primarysponsorcountry>New Zealand</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Government body</fundingtype>
      <fundingname>Health Research Council of NZ</fundingname>
      <fundingaddress>Grafton Rd, Grafton, Auckland</fundingaddress>
      <fundingcountry>New Zealand</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>University</sponsortype>
      <sponsorname>University of Auckland</sponsorname>
      <sponsoraddress>rivate BAg 92019, Auckland</sponsoraddress>
      <sponsorcountry>New Zealand</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary />
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Northern X Ethics Committee</ethicname>
      <ethicaddress>Auckland</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>New Zealand</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Ngaire Kerse</name>
      <address>Department of General Practice and Primary Health Care
School of Population Health
University of Auckland
Glen Innes 1065</address>
      <phone>+64 9 3737599 ext. 84467</phone>
      <fax>+64 9 3737624</fax>
      <email>n.kerse@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Kathy Peri</name>
      <address>Department of General Practice and Primary Health Care
School of Population Health
University of Auckland
Glen Innes 1065</address>
      <phone>+64 9 3737999</phone>
      <fax />
      <email>k.peri@auckland.ac.nz</email>
      <country>New Zealand</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>